Recently, SIRT1 was found to be highly expressed in various cancers [41, 42], and high levels of SIRT1 expression were shown to be associated with a poor prognosis in lung cancer, breast cancer, B-cell lymphoma, and gastric carcinomas [43–45]. Here, SIRT1 is linked to lung carcinoma.